Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer.
Purity:
98.5%
CAS Number:
[1350624-75-7]
Target:
EGFR/HER2
* VAT and and shipping costs not included. Errors and price changes excepted